Girgis, A.S.; Zhao, Y.; Nkosi, A.; Ismail, N.S.M.; Bekheit, M.S.; Aboshouk, D.R.; Aziz, M.N.; Youssef, M.A.; Panda, S.S.
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation. Pharmaceuticals 2025, 18, 274.
https://doi.org/10.3390/ph18020274
AMA Style
Girgis AS, Zhao Y, Nkosi A, Ismail NSM, Bekheit MS, Aboshouk DR, Aziz MN, Youssef MA, Panda SS.
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation. Pharmaceuticals. 2025; 18(2):274.
https://doi.org/10.3390/ph18020274
Chicago/Turabian Style
Girgis, Adel S., Yujun Zhao, Angel Nkosi, Nasser S. M. Ismail, Mohamed S. Bekheit, Dalia R. Aboshouk, Marian N. Aziz, M. Adel Youssef, and Siva S. Panda.
2025. "The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation" Pharmaceuticals 18, no. 2: 274.
https://doi.org/10.3390/ph18020274
APA Style
Girgis, A. S., Zhao, Y., Nkosi, A., Ismail, N. S. M., Bekheit, M. S., Aboshouk, D. R., Aziz, M. N., Youssef, M. A., & Panda, S. S.
(2025). The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation. Pharmaceuticals, 18(2), 274.
https://doi.org/10.3390/ph18020274